intelligence360

The Intelligent News Source

Tag: Be Biopharma

Be Bio Announces $82 Million Financing and Transition to Clinical Stage Company

October 22, 2024 12:00 PM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Be Biopharma, Inc. (“Be Bio” or “the Company”), a leader in the discovery and development of engineered B Cell Medicines (BCMs), today announced key milestones…

intelligence360

Source: http://www.intelligence360.io/ and https://intelligence360.news/

Spot AI, a leader in AI camera systems, today announced the launch of its Video AI Agents, marking a significant milestone in bringing agentic AI capabilities from the digital to the physical world. Video AI Agents help organizations instantly surface and resolve incidents across safety, security, and operations, delivering measurable ROI across manufacturing, education, retail, and auto services. In addition to the launch of its flagship product, Spot AI has secured $31 million in new equity funding, bringing the total raised to $93 million. The latest round saw new investor Qualcomm Ventures participate alongside existing investors Scale Venture Partners, StepStone Group, Redpoint Ventures, and Bessemer Venture Partners. The round also saw participation from GSBackers, MVP Ventures, and Cheyenne Ventures.

In a statement Rish Gupta, CEO of Spot AI said, “Eighty percent of our understanding of the world happens through eyes. That’s why we’re dedicated to helping our customers turn their video cameras into additional teammates.” “Our AI Agents see your physical space, use advanced AI to reason about what’s happening, and take actions in real-time. This funding allows us to push the boundaries of what’s possible and bring the power of AI from the screen to the physical spaces where we live and work.”

Spot AI today serves 1,000 customers across 17 industries, indexing more than twice the amount of video uploaded daily to YouTube, to make video data as accessible and actionable as any other type of data in industries facing safety risks, operational hurdles and productivity loss due to labor shortages and security breaches.

Source: http://www.intelligence360.io/ and https://intelligence360.news/

Armis, the cyber exposure management & security company, announced the close of a $200 million Series D round of investment, increasing its total company valuation to a new high of $4.2 billion. Armis’ latest funding round was led by both top-tier investors General Catalyst and Alkeon Capital, along with existing investors Brookfield Technology Partners and Georgian. The additional capital will enable Armis to continue with its 5 year strategy to build a multi-generational cybersecurity company, fuel strong organic product innovation and global go-to-market programs, while simultaneously taking advantage of game changing inorganic growth opportunities that may arise.

This new round of funding comes after Armis recently announced it had surpassed the 200 USD million in Annual Recurring Revenue (ARR) mark, growing ARR by an additional $100 million in less than 18 months. The company is targeting a future IPO, and building a multi-generational company with the next major milestones being reaching the $500 Million ARR milestone along the journey to $1 billion ARR and beyond.

Yevgeny Dibrov, CEO and Co-Founder of Armis, commented on the latest round of investments and the long-term potential they unlock: “My Co-founder Nadir Izrael and I are incredibly grateful for the support of General Catalyst and Alkeon Capital as well as Brookfield and Georgian. Their investment and belief in Armis’ future reflect the strength of our platform and the market need for a comprehensive Cyber Exposure Management platform – from asset management and Cyber Physical systems security to Remediation of vulnerabilities and issues from IT to cloud and the CI/CD pipeline. We remain confident that this is just the beginning for Armis, and we look forward to delivering on our vision of a safer digital world.”

Load More... Subscribe